AgriMetis Expands by Adding an Associate Director of Process Chemistry
LUTHERVILLE, MD – August 14, 2018 – AgriMetis, LLC is pleased to announce that Dr. Rachel Witek has joined the company as its Associate Director of Process Chemistry. Rachel will lead AgriMetis’ process development and scale-up efforts on the SpinoMetis™ program. Rachel will also support the company’s efforts in L-Glufosinate process and scale-up under the direction of Matt Oberholzer, VP of Process Technology.
Rachel comes to AgriMetis with ten years of process research, development and scale-up experience with the last seven years spent in the biotech industry. In her most recent role, Rachel implemented several successful manufacturing process transfers of multiple product lines to new production sites and was instrumental to the development and commercialization of several cell, PCR, and media products for a multinational biotech company. Prior to that role, Rachel worked in a multinational agrochemical company and was responsible for research and development of synthetic routes, scale up and process transfer to manufacturing site for a crop protection safener.
“AgriMetis has had strong Product Research and Development leadership since its founding. We are excited to have Rachel adding Process Chemistry expertise, while also bringing significant biotech and agrichemical experience to our team. AgriMetis’ strength is our creative, collaborative, and skilled process technical management team. We look forward to Rachel's contribution of her significant expertise to our efforts,” said Steven Tuttle, AgriMetis’ President and CEO.
AgriMetis avails the interface of biology, biochemistry, and chemistry to access areas of chemical space and production routes that are not available to others.
In an evolving and growing global population, there continues to be an increasing demand for sustainable, crop protection products. AgriMetis is committed to working with leading agriculture companies and businesses to fill this emerging need.
Our mission is to innovate sustainable crop protection products through leading edge and advanced discovery, development and delivery methods.
The AgriMetis technology platform is at the interface of biology, biochemistry, and chemistry. AgriMetis’ scientific approach is multidisciplinary and integrated, which allows AgriMetis to exploit areas of chemical space and production routes that are inaccessible to others.
AgriMetis was formed in March 2014 and completed a Series B financing in December 2016 to fund agriculture chemical research and development by applying a biopharmaceutical model. With headquarters near Baltimore, Maryland, AgriMetis continues to grow and develop its technologies and capabilities.
For more information, please visit our website at http://www.agrimetis.com
This press release contains “forward-looking statements” concerning the development of AgriMetis’ products, the potential benefits and attributes of such products, and the company’s expectations regarding its prospects. Forward-looking statements are subject to risks, assumptions and uncertainties that could cause actual future events or results to differ materially from such statements. These statements are made as of the date of this press release. Actual results may vary. AgriMetis undertakes no obligation to update any forward-looking statements for any reason